96. クローン病 Crohn disease Clinical trials / Disease details
臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04974099 (ClinicalTrials.gov) | October 1, 2021 | 29/6/2021 | Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease | Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease | Crohn Disease | Device: RoadMAB;Drug: Precision dosing with a dashboard | Children's Hospital Medical Center, Cincinnati | Crohn's and Colitis Foundation | Recruiting | 6 Years | 22 Years | All | 20 | Phase 2/Phase 3 | United States |